Pulmonary complications of sickle cell anemia. A need for increased recognition, treatment, and research.
Minter
K R
KR
Critical Care Medicine Department, Clinical Center, and Laboratory of Chemical Biology, National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, Bethesda, Maryland 20892-1662, USA.
Gladwin
M T
MT
D000208:Acute Disease; D000755:Anemia, Sickle Cell / Q000150:complications* / Q000453:epidemiology / Q000235:genetics; D015982:Bias; D044383:Black People / Q000235:genetics; D002423:Cause of Death; D002908:Chronic Disease; D006801:Humans; D006976:Hypertension, Pulmonary / Q000175:diagnosis / Q000209:etiology* / Q000401:mortality / Q000628:therapy*; D008171:Lung Diseases / Q000175:diagnosis / Q000209:etiology* / Q000401:mortality / Q000628:therapy*; D008403:Mass Screening; D020380:Needs Assessment; D011655:Pulmonary Embolism / Q000175:diagnosis / Q000209:etiology* / Q000401:mortality / Q000628:therapy*; D011658:Pulmonary Fibrosis / Q000175:diagnosis / Q000209:etiology* / Q000401:mortality / Q000628:therapy*; D012106:Research; D012307:Risk Factors; D014481:United States / Q000453:epidemiology; D001741:Black or African American